•  
  •  
  •  
  •  

2025-10-07 22:29:40

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain

Keywords Selected:  Alankit

Stock Report

  • Alankit Ltd gets approval for increase of recruitment license capacity
  • Alankit Ltd enters into agreement with State Health Agency under AB PMJAY and MA Yojana, Gujarat
  • Alankit Ltd successfully renews empanelled Service Agreement with Central Bank of India
  • Alankit Ltd posts consolidated profit of Rs. 7.40 crores in Q1 FY25
  • Alankit Ltd awarded contract by Samagra Shiksha
  • Alankit Ltd Q4FY2023 consolidated PAT up at Rs. 4.71 crores
  • Alankit Ltd Q2FY23 consolidated loss at Rs. 46.29 crores
  • CARE withdraws rating of Alankit Ltd
  • Alankit Ltd recommends final dividend of Rs. 0.20
  • Alankit Ltd Q3FY22 consolidated PAT up QoQ at Rs. 2.08 crores
  • Alankit Ltd Q2FY22 consolidated PAT drops to Rs. 48.69 lakhs

Latest Post

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024